The top 6 most interesting things in ASX small caps today. 1,284 stocks analysed.
#1
AUK jumped +50.0% on 10x normal volume — one of today's biggest movers
AUK (Consumer Cyclical) had a cracking session, climbing +50.0%. Scout scores it 31/100. Moves this size don't usually happen without a reason — worth checking what's behind it.
#2
LSR jumped +46.2% on 4x normal volume — one of today's biggest movers
LSR (Basic Materials) had a cracking session, climbing +46.2%. Scout scores it 37/100. Moves this size don't usually happen without a reason — worth checking what's behind it.
#3
TLX gained +5.9% despite 15.1% short interest — squeeze potential?
Here's an interesting one: 15.1% of TLX's shares are sold short, yet the stock climbed +5.9% today. When shorts get caught on the wrong side, they're forced to buy back — which can pour fuel on the fire.
#4
GYG gained +1.0% despite 13.3% short interest — squeeze potential?
Here's an interesting one: 13.3% of GYG's shares are sold short, yet the stock climbed +1.0% today. When shorts get caught on the wrong side, they're forced to buy back — which can pour fuel on the fire.
#5
CAE scores 56/100 but sitting 66% below its 52-week high
This is a classic contrarian setup: CAE (Basic Materials) is scoring well across Scout's dimensions, but the market has it beaten down. When the data says one thing and the price says another, something's got to give.
#6
BOE scores 56/100 but sitting 66% below its 52-week high
This is a classic contrarian setup: BOE (Energy) is scoring well across Scout's dimensions, but the market has it beaten down. When the data says one thing and the price says another, something's got to give.
GENERAL INFORMATION ONLY — This article is produced by an algorithm and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. SmallCapData does not hold an Australian Financial Services Licence (AFSL). You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results.